DIFFERENCES IN ACTIVITY OF TCR-T CELLS TARGETING MINOR HISTOCOMPATIBILITY ANTIGENS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES von Keshavarzian, N., Minguy, A., Masroori, N., Bastien, J., Trottier, J., Dardon, J., Dave, V., Roy, D.

Volltext

Establishment of a cell line expressing recombinant factor VII and its subsequent conversion to active form FVIIa through hepsin by genetic engineering method von Halabian, R., Roudkenar, M. H., Esmaeili, N. S., Masroori, N., Roushandeh, A. M., Najafabadi, A. J.

Volltext

Immunotherapy: ENGINEERING T CELL TARGETING MINOR HISTOCOMPATIBILITY ANTIGENS von Masroori, N., Minguy, A., Sawchyn, C., Mathieu, C., Trottier, J., Bastien, J., Sanchez-Dardon, J., Dave, V., Mallette, F., Roy, D.

Volltext

1056 - Immunotherapy: ENGINEERING T CELL TARGETING MINOR HISTOCOMPATIBILITY ANTIGENS von Masroori, N., Minguy, A., Sawchyn, C., Mathieu, C., Trottier, J., Bastien, J., Sanchez-Dardon, J., Dave, V., Mallette, F., Roy, D.

Volltext

Case Report: ISG15 deficiency caused by novel variants in two families and effective treatment with Janus kinase inhibition von Burleigh, A, Moraitis, E, Al Masroori, E, Al-Abadi, E, Hong, Y, Omoyinmi, E, Titheradge, H, Stals, K, Jones, WD, Gait, A, Jayarajan, V, Di, WL, Sebire, N, Solman, L, Ogboli, M, Welch, SB, Sudarsanam, A, Wacogne, I, Price-Kuehne, F, Jensen, B, Brogan, PA, Eleftheriou, D

Volltext bestellen